Preview
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
SUPREME COURT OF THE STATE OF NEW YORK
COUNTY OF NEW YORK: COMMERCIAL DIVISION
SONNY ST. JOHN, Individually and on Behalf of All
Others Similarly Situated, Index No. 652617/2021
Plaintiff,
Part 53: Hon. Andrew Borrok
v.
CLOOPEN GROUP HOLDING LIMITED, ORAL ARGUMENT REQUESTED
CHANGXUN SUN, YIPENG LI, KUI ZHOU,
QINGSHENG ZHENG, XIAODONG LIANG, ZI
YANG, MING LIAO, FENG ZHU, LOK YAN HUI,
JIANHONG ZHOU, CHING CHIU, COGENCY
GLOBAL INC., COLLEEN A. DEVRIES, GOLDMAN
SACHS (ASIA) L.L.C., CITIGROUP GLOBAL
MARKETS INC., CHINA INTERNATIONAL
CAPITAL CORPORATION HONG KONG
SECURITIES LIMITED, TIGER BROKERS (NZ)
LIMITED, and FUTU, INC.,
Defendants.
MEMORANDUM OF LAW IN SUPPORT OF PLAINTIFFS’ MOTION FOR FINAL
APPROVAL OF CLASS ACTION SETTLEMENT AND PLAN OF ALLOCATION
Max R. Schwartz
Emilie B. Kokmanian
Mandeep S. Minhas
SCOTT+SCOTT ATTORNEYS AT LAW LLP
The Helmsley Building
230 Park Avenue, 17th Floor
New York, New York 10169
Telephone: (212) 223-6444
Facsimile: (212) 223-6334
mschwartz@scott-scott.com
ekokmanian@scott-scott.com
mminhas@scott-scott.com
Counsel for Plaintiff Sonny St. John
1 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
TABLE OF CONTENTS
INTRODUCTION .......................................................................................................................... 1
FACTUAL AND PROCEDURAL BACKGROUND.................................................................... 2
ARGUMENT .................................................................................................................................. 2
I. THE SETTLEMENT IS FAIR, REASONABLE, AND ADEQUATE,
AND SHOULD BE APPROVED .......................................................................... 2
A. Colt Factor One: Likelihood of Success on the Merits and Amount
Recovered in Light of Litigation Risks....................................................... 3
B. Colt Factors Two Through Four: Extent of Support from the
Parties, Judgment of Counsel, and Presence of Good-Faith
Bargaining ................................................................................................. 11
C. Colt Factor Five: Complexity and Nature of Case.................................... 12
II. THE PLAN OF ALLOCATION IS FAIR AND ADEQUATE ........................... 13
III. THE SETTLEMENT CLASS SHOULD BE CERTIFIED .................................. 15
A. The Settlement Class Easily Satisfies CPLR 901 ..................................... 15
B. CPLR 902’s Discretionary Factors Also Support Certification................ 17
IV. NOTICE TO THE CLASS SATISFIED THE REQUIREMENTS OF
ARTICLE 9 OF THE CPLR AND DUE PROCESS ........................................... 18
CONCLUSION ............................................................................................................................. 19
i
2 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
TABLE OF AUTHORITIES
Page(s)
Cases
Borden v. 400 E. 55th St. Assocs., L.P.,
24 N.Y.3d 382 (2014) ..............................................................................................................16
City Trading Fund v. Nye,
72 N.Y.S.3d 371 (Sup. Ct., N.Y. Cnty. 2018) .........................................................................12
Denburg v. Parker Chapin Flattau & Klimpl,
82 N.Y.2d 375 (1993) ................................................................................................................3
Dura Pharms., Inc. v. Broudo,
544 U.S. 336 (2005) ...................................................................................................................7
Fed. Hous. Fin. Agency for Fed. Nat’l Mortg. Ass’n v. Nomura Holding Am., Inc.,
873 F.3d 85 (2d Cir. 2017).....................................................................................................6, 9
Fernandez v. Legends Hosp., LLC,
No. 152208/2014, 2015 WL 3932897 (Sup. Ct., N.Y. Cnty. June 22, 2015) ............................3
Fiala v. Metro. Life Ins. Co., Inc.,
899 N.Y.S.2d 531 (Sup. Ct., N.Y. Cnty. 2010) .......................................................................12
Fishoff v. Coty Inc.,
No. 09 Civ. 628, 2010 WL 305358 (S.D.N.Y. Jan. 25, 2010), aff’d 634 F.3d
647 (2d Cir. 2011) ......................................................................................................................7
Glam & Glitz Nail Design, Inc. v. iGel Beauty, LLC,
No. SA CV 20-00088, 2022 WL 17078947 (C.D. Cal. Sept. 30, 2022)....................................6
Gordon v. Verizon Commc’ns,
148 A.D.3d 146 (App. Div. 1st Dep’t 2017) .................................................................3, 11, 12
Hosue v. Calypso St. Barth, Inc.,
No. 160400/2015, 2017 WL 4011213 (Sup. Ct., N.Y. Cnty. Sept. 12, 2017) ...........................3
Hubbard v. BankAtlantic Bancorp, Inc.,
688 F.3d 713 (11th Cir. 2012) ...................................................................................................8
IDT Corp. v. Tyco Grp., S.A.R.L.,
13 N.Y.3d 209 (2009) ................................................................................................................2
In re Advanced Battery Techs., Inc. Sec. Litig.,
298 F.R.D. 171 (S.D.N.Y. 2014) .............................................................................................13
ii
3 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
In re Am. Bank Note Holographics, Inc.,
127 F. Supp. 2d 418 (S.D.N.Y. 2001)........................................................................................7
In re Bayer AG Sec. Litig.,
No. 03 Civ. 1546, 2008 WL 5336691 (S.D.N.Y. Dec. 15, 2008) ..............................................3
In re Colt Indus. S’holder Litig.,
155 A.D.2d 154 (App. Div. 1st Dep’t 1990) .................................................................3, 11, 12
In re Dozier Fin., Inc.,
No. 4:18-cv-1888, 2018 WL 4599860 (D.S.C. Sept. 6, 2018), report adopted,
2019 WL 1075072 (D.S.C. Mar. 7, 2019) .................................................................................4
In re Giant Interactive Grp., Inc. Sec. Litig.,
279 F.R.D. 151 (S.D.N.Y. 2011) ...............................................................................................7
In re Glob. Crossing Sec. and ERISA Litig.,
225 F.R.D. 436 (S.D.N.Y. 2004) ...............................................................................................8
In re SunEdison, Inc. Sec. Litig.,
329 F.R.D. 124 (S.D.N.Y. 2019) .......................................................................................16, 17
In re Telik, Inc. Sec. Litig.,
576 F. Supp. 2d 570 (S.D.N.Y. 2008)........................................................................................7
In re WorldCom, Inc. Sec. Litig.,
388 F. Supp. 2d 319 (S.D.N.Y. 2005)......................................................................................13
Klein v. Robert’s Am. Gourmet Food, Inc.,
28 A.D.3d 63 (App. Div. 2d Dep’t 2006) ..............................................................................3, 9
Lea v. TAL Educ. Grp.,
837 F. App’x 20 (2d Cir. 2020) .................................................................................................5
Maley v. Del Glob. Techs. Corp.,
186 F. Supp. 2d 358 (S.D.N.Y. 2002)......................................................................................14
Nawrocki v. Proto Constr. & Dev. Corp.,
No. 104229/2007, 2010 WL 1531428 (Sup. Ct. N.Y. Cnty. Apr. 7, 2010),
aff’d, 82 A.D.3d 534 (App. Div. 1st Dep’t 2011) ....................................................................17
Patel v. L-3 Commc'ns Holdings Inc.,
No. 14-CV-6038-VEC, 2016 WL 1629325 (S.D.N.Y. Apr. 21, 2016) .....................................5
Pressner v. MortgageIT Holdings, Inc.,
No. 602472/2006, 2007 WL 1794935 (Sup. Ct. N.Y. Cnty. May 29, 2007) ...........................11
iii
4 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
Pruitt v. Rockefeller Ctr. Props., Inc.,
167 A.D.2d 14 (App. Div. 1st Dep’t 1991) .................................................................15, 16, 17
Ret. Fund v. J.P. Morgan Chase & Co.,
301 F.R.D. 116 (S.D.N.Y. 2014) .............................................................................................15
Ret. Sys. v. Morgan Stanley & Co.,
772 F.3d 111 (2d Cir. 2014).....................................................................................................16
Saska v. Metro. Museum of Art,
54 N.Y.S.3d 566 (Sup. Ct., N.Y. Cnty. 2017) .........................................................................12
Stecko v. RLI Ins. Co.,
121 A.D.3d 542 (App. Div. 1st Dep’t 2014) ...........................................................................17
Sykes v. Mel S. Harris & Assocs. LLC,
780 F.3d 70 (2d Cir. 2015).......................................................................................................16
Wal-Mart Stores, Inc. v. Visa U.S.A., Inc.,
396 F.3d 96 (2d Cir. 2005).........................................................................................................3
Zimmerman v. Portfolio Recovery Assocs., LLC,
No. 09 CIV. 4602, 2013 WL 6508813 (S.D.N.Y. Dec. 12, 2013)...........................................14
Statutes
15 U.S.C.
§78t(a) ........................................................................................................................................5
§78j(b) ........................................................................................................................................5
17 C.F.R.
§240.10b-5 .................................................................................................................................5
Civil Practice Law and Rules
Rule 901 .............................................................................................................................15, 17
Rule 901(1) ..............................................................................................................................15
Rule 901(3) ..............................................................................................................................16
Rule 901(4) ..............................................................................................................................17
Rule 901(5) ..............................................................................................................................17
Rule 902 .......................................................................................................................15, 17, 18
Other Authorities
Janeen McIntosh, et al., Recent Trends In Securities Class Action Litigation:
2022 Full-Year Review, NERA ECON. CONSULTING (Jan. 25, 2022) ......................................10
Laarni T. Bulan & Laura E. Simmons, Securities Class Action Settlements:
2022 Review and Analysis, CORNERSTONE RESEARCH (2022) ................................................10
iv
5 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
U.S. Dep’t of State, Bureau of Consular Affairs, Taking Voluntary Depositions of
Willing Witnesses, China Judicial Assistance Information (2019) ...........................................6
v
6 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
Plaintiffs (consisting of State Class Representative Sonny St. John, together with Federal
Plaintiff Guozhang Wang in the related Federal Action1) respectfully submit this brief in support
of Plaintiffs’ Motion for Final Approval of Class Action Settlement and Plan of Allocation. The
proposed Settlement’s terms are set forth in the Stipulation of Settlement (the “Stipulation”) filed
on August 16, 2023 (NYSCEF No. 107).2
INTRODUCTION
After more than two years of litigation, the Parties in this State Action and in the
substantively similar action brought on behalf of the same Class in the related Federal Action
(collectively, the “Actions”) have agreed to settle, on a global basis, all claims asserted against all
Defendants in both Actions for $12,000,000 in cash.3 The Plaintiffs in both Actions allege that
Defendants violated the federal securities laws by making misstatements and omissions of material
fact in the Offering Materials for Cloopen Group Holding Limited’s (“Cloopen”) February 9, 2019
initial public offering of Cloopen American Depository Shares (“ADS”).
The proposed $12 million Settlement was reached only after vigorously contested motions
to dismiss practice in both Actions, approximately nine months of fact discovery and the
certification of a class in the State Action, and protracted arm’s-length settlement negotiations
1
The Federal Action refers to the substantively similar action brought in the United States
District Court for the Southern District of New York on behalf of a substantially similar Class of
investors, captioned Dong v. Cloopen Group Holding Limited, et al., No 1:21-cv-10610-JGK-
RWL (S.D.N.Y.).
2
Unless otherwise indicated herein: (1) all capitalized terms have the meanings set forth in
the Stipulation; and (2) in quoted material, unless otherwise indicated, all citations and internal
quotation marks are omitted and all emphasis is added.
3
After being advised of the Settlement, the Federal Court dismissed the Federal Action with
prejudice. Order entered June 6, 2023 (ECF No. 135). Unless otherwise indicated or referenced
to the above-captioned action (i.e., “NYSCEF No.”), all ECF No. references are to the Federal
Action, Dong v. Cloopen Grp. Holding Ltd., No. 1:21-cv-10610-JGK-RWL (S.D.N.Y.).
1
7 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
overseen by a highly experienced mediator, Robert Meyer, Esq., of JAMS (the “Mediator”).
Plaintiffs and their counsel respectfully submit that this Settlement represents an excellent
recovery in the face of very substantial litigation risk and collectability issues. Moreover, although
individual “Notice Packets” have been mailed to over 4,900 potential Settlement Class Members
or their nominees, to date, no objections or “opt-out” requests have been received. See
accompanying Joint Affirmation of Max R. Schwartz and Michael Dell’Angelo (“Joint Aff.”), ¶8;
Affidavit of Eric Schachter Regarding: (A) Mailing of Notice and Claim Form; (B) Publication of
Summary Notice; and (C) Report on Requests for Exclusion Received to Date (“Schachter Aff.”),
¶¶5, 16. For these and the other reasons detailed herein, the Settlement easily meets the CPLR’s
standards for approval.
Additionally, the proposed Plan of Allocation (“POA”), designed by Plaintiffs’ damages
expert, provides for a customary pro rata distribution of the Net Settlement proceeds to Settlement
Class Members and should also be approved.
FACTUAL AND PROCEDURAL BACKGROUND
Plaintiffs respectfully refer the Court to the accompanying Joint Affirmation for a detailed
discussion of the history of the Actions, the extensive work performed by Plaintiffs’ Counsel, the
risks of continued litigation, and the negotiations under the independent Mediator’s auspices that
led to the Settlement. Joint Aff., ¶¶13-57.
ARGUMENT
I. THE SETTLEMENT IS FAIR, REASONABLE, AND ADEQUATE, AND SHOULD
BE APPROVED
New York courts strongly favor settlements as a matter of public policy. IDT Corp. v. Tyco
Grp., S.A.R.L., 13 N.Y.3d 209, 213 (2009) (“stipulations of settlement are judicially favored and
may not be lightly set aside”). “Strong policy considerations favor” settlements because “[a]
2
8 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
negotiated compromise of a dispute avoids potentially costly, time-consuming litigation and
preserves scarce judicial resources; courts could not function if every dispute devolved into a
lawsuit.” Denburg v. Parker Chapin Flattau & Klimpl, 82 N.Y.2d 375, 383 (1993); accord Wal-
Mart Stores, Inc. v. Visa U.S.A., Inc., 396 F.3d 96, 116 (2d Cir. 2005) (citing “strong judicial
policy” favoring settlements).
When considering whether to finally approve a class action settlement, New York courts
focus on “the fairness of the settlement, its adequacy, its reasonableness, and the best interests of
the class members.” Hosue v. Calypso St. Barth, Inc., No. 160400/2015, 2017 WL 4011213, at *2
(Sup. Ct., N.Y. Cnty. Sept. 12, 2017). Specifically, New York courts consider: (i) the likelihood
that plaintiffs will succeed on the merits; (ii) the extent of support from the parties; (iii) counsel’s
judgment; (iv) the presence of good-faith bargaining; and (v) the complexity of the legal and
factual issues. See Fernandez v. Legends Hosp., LLC, No. 152208/2014, 2015 WL 3932897, at
*2 (Sup. Ct., N.Y. Cnty. June 22, 2015). In addition, in analyzing the likelihood of success on the
merits, courts have noted that finding “adequacy” involves “balancing the value of [a] settlement
against the present value of the anticipated recovery following a trial on the merits, discounted for
the inherent risks of litigation.” Klein v. Robert’s Am. Gourmet Food, Inc., 28 A.D.3d 63, 73 (App.
Div. 2d Dep’t 2006). These factors, commonly referred to as the “Colt factors” (after In re Colt
Indus. S’holder Litig., 155 A.D.2d 154 (App. Div. 1st Dep’t 1990)), all favor approval here.
A. Colt Factor One: Likelihood of Success on the Merits and Amount Recovered
in Light of Litigation Risks
When assessing a proposed class action settlement, courts first consider the plaintiff’s
likelihood of ultimate success on the merits. Gordon v. Verizon Commc’ns, 148 A.D.3d 146, 162
(App. Div. 1st Dep’t 2017); Colt, 155 A.D.2d at 160. As a general matter, securities actions are
“notoriously complex and difficult to prove.” In re Bayer AG Sec. Litig., No. 03 Civ. 1546, 2008
3
9 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
WL 5336691, at *5 (S.D.N.Y. Dec. 15, 2008); see also In re Dozier Fin., Inc., No. 4:18-cv-1888,
2018 WL 4599860, at *3 (D.S.C. Sept. 6, 2018), report adopted, 2019 WL 1075072 (D.S.C. Mar.
7, 2019) (collecting cases finding that “securities [cases] [. . .] are neither straightforward nor
routine.”). This case was no exception.
Although Defendants’ motions to dismiss were denied in both Actions (NYSCEF No. 74;
ECF No. 113), Plaintiffs recognize that proving the necessary facts to prevail on the merits would
be challenging, and that surviving summary judgment was not guaranteed. The risks of litigation
here were plainly substantial, and some of the challenges that Plaintiffs faced in establishing
liability on the claims that they propose to settle were made clear early on. For example, Plaintiffs
expected Cloopen to continue to advance the argument that it had no duty to disclose its declining
Net Customer Retention Rate during Q4 2020 financials because it contended that, at the time the
Prospectus was filed, this was “interim data” under Section 11 or Item 303. Plaintiffs expected
Cloopen would also continue to advance arguments that the Registration Statement contained
detailed and specific warnings, including 60 pages of risk factors, that warned about competitive
and financial risks and disclosed the trends of increasing losses, increasing accounts receivable,
and decreasing Retention Rates that were allegedly omitted. Further, Defendants would continue
to contend that the Registration Statement provided explicit and extensive disclosures about the
Series F Warrants, and contrary to Plaintiffs’ allegations, disclosed that the warrant liabilities were
subject to remeasurement at each reporting period. While Plaintiffs disputed these arguments,
Plaintiffs recognize that each of them created material uncertainty regarding the ultimate outcome
of the Actions at summary judgment or trial, where legal arguments are based on factual
sufficiency, in contrast to the more liberal, plaintiff-friendly standards applied at the pleadings
stage. Joint Aff., ¶¶60-74.
4
10 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
Likewise, in the Federal Action, Federal Plaintiff brought claims under Section 10(b) of
the Securities Exchange Act of 1934 (the “Exchange Act”), 15 U.S.C. §78j(b), and Rule 10b-5
promulgated thereunder, 17 C.F.R. §240.10b-5, as well as Section 20(a) of the Exchange Act, 15
U.S.C. §78t(a). Those claims require proof of the element of scienter. “The scienter needed to
sustain a Section 10(b) claim is intent to deceive, manipulate, or defraud, or at least knowing
misconduct.” ECF No. 113 at 38 (internal quotations omitted). While the court in the Federal
Action held that Federal Plaintiff sufficiently pled scienter (id. at 50), the burden of pleading
scienter is less exacting than the burden of proving it. See Lea v. TAL Educ. Grp., 837 F. App’x
20, 23 (2d Cir. 2020) (quoting Tellabs, Inc. v. Makor Issues & Rts., Ltd., 551 U.S. 308, 328-29
(2007)) (“To allege a strong inference of scienter, a plaintiff ‘must plead facts rendering an
inference of scienter at least as likely as any plausible opposing inference,’ unlike at trial where a
plaintiff must prove scienter by a preponderance of the evidence, i.e., ‘that it is more likely than
not that the defendant acted with scienter.’”); Patel v. L-3 Commc'ns Holdings Inc., No. 14-CV-
6038-VEC, 2016 WL 1629325, at *15 (S.D.N.Y. Apr. 21, 2016) (“Although Lead Plaintiffs have
pled a strong inference of corporate scienter for the purpose of surviving Defendants’ Motion to
Dismiss, to survive summary judgment or to win at trial, Lead Plaintiffs will need to prove that
the Aerospace Systems CFO acted with the requisite scienter at the time of each of the alleged
misstatements in order for L-3 to be held liable for the alleged Section 10(b) violation.”) (emphasis
in original).
Plaintiffs also faced an uphill battle in obtaining proof of their claims because most of the
evidence in this case is located in the People’s Republic of China. Plaintiffs’ ability to obtain
deposition discovery was uncertain, as virtually all relevant witnesses are located there, and “China
has indicated that taking depositions, whether voluntary or compelled, and obtaining other
5
11 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
evidence in China for use in foreign courts may, as a general matter, only be accomplished through
requests to its Central Authority under the Hague Evidence Convention” – an extensive, multi-
year process during which evidence will disperse and witnesses’ memories will fade. U.S. Dep’t
of State, Bureau of Consular Affairs, Taking Voluntary Depositions of Willing Witnesses, China
Judicial Assistance Information (2019)4; see also Glam & Glitz Nail Design, Inc. v. iGel Beauty,
LLC, No. SA CV 20-00088, 2022 WL 17078947, at *3 (C.D. Cal. Sept. 30, 2022). Further, while
Cloopen had begun to collect and review documents in response to Plaintiffs’ discovery demands,
it took the position that it was unable to produce any documents while Chinese regulators
considered whether Cloopen’s documents or data, stored within mainland China, could be
produced in litigation in the United States. In sum, the risk of being unable to collect relevant
evidence was far greater here than in cases where all relevant witnesses and documents are located
in the United States or in countries that are more willing to assist foreign litigants than China. In
addition, the bulk of the documents located in China, if they were produced at all, were likely to
be produced in Chinese, requiring translation and creating an additional cost and layer of
complexity not present in the ordinary securities class action. Joint Aff., ¶¶60-74.
Even if Plaintiffs prevailed on liability, Defendants had colorable “negative loss causation”
arguments – i.e., that some of the Class’s alleged damages resulted from factors other than belated
disclosures that the Offering Documents contained the alleged material misstatements and
omissions. See Fed. Hous. Fin. Agency for Fed. Nat’l Mortg. Ass’n v. Nomura Holding Am., Inc.,
873 F.3d 85, 99 (2d Cir. 2017). Defendants raised negative causation defenses ranging from
macroeconomic factors that they say caused the drop in Cloopen’s ADS, to factors unrelated to
4
Available at https://travel.state.gov/content/travel/en/legal/Judicial-Assistance-Country-
Information/China.html (last visited Dec. 15, 2023).
6
12 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
the undisclosed information that purportedly contributed to those drops, to the timing of when the
allegedly undisclosed information was released relative to the drop in the price of Cloopen’s ADS.
Joint Aff., ¶¶67-69. Such causation issues all too frequently come down to inherently
unpredictable “battles of the experts,” and an adverse result could have easily gutted the value of
Plaintiffs’ otherwise meritorious claims. See, e.g., In re Am. Bank Note Holographics, Inc., 127
F. Supp. 2d 418, 426-27 (S.D.N.Y. 2001) (“In [a] ‘battle of experts,’ it is virtually impossible to
predict with any certainty which testimony would be credited [and] which damages would be
found to have been caused by actionable, rather than the myriad nonactionable factors[. . . .]”)
(internal quotation marks in original); In re Giant Interactive Grp., Inc. Sec. Litig., 279 F.R.D.
151, 161-62 (S.D.N.Y. 2011) (approving settlement where litigation risk included credible
causation defenses).
Further, in the Federal Action, Defendants have strenuously argued, and would continue to
argue, that even if Lead Plaintiff could establish a material misstatement or omission, he could not
prove the requisite mental state of scienter – i.e., that Defendants misled investors intentionally or
with extreme recklessness. See also Joint Aff., ¶62. The scienter requirement is regarded as “the
most difficult and controversial aspect of a securities fraud claim.” Fishoff v. Coty Inc., No. 09
Civ. 628, 2010 WL 305358, at *2 (S.D.N.Y. Jan. 25, 2010), aff’d 634 F.3d 647 (2d Cir. 2011); see
also In re Telik, Inc. Sec. Litig., 576 F. Supp. 2d 570, 579 (S.D.N.Y. 2008) (“[p]roving a
defendant’s state of mind is hard in any circumstances.”).
Likewise, if the Federal Action had proceeded, Federal Plaintiff would also have
encountered significant loss causation and damages defenses relating to the Exchange Act claims
at the summary judgment phase and trial. Pursuant to Dura Pharms., Inc. v. Broudo, 544 U.S.
336, 345-47 (2005), Federal Plaintiff would need to show that it was the disclosure of the alleged
7
13 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
securities violations that caused investors’ losses, as opposed to other unrelated matters. See also
Joint Aff., ¶68. Establishing loss causation is a “complicated and uncertain process, typically
involving conflicting expert opinion[s],” In re Glob. Crossing Sec. and ERISA Litig., 225 F.R.D.
436, 459 (S.D.N.Y. 2004), and Defendants have strongly contested loss causation.
Even if Plaintiffs survived summary judgment and prevailed across the board on liability,
causation, and damages issues at trial, there would still be no assurance that a favorable jury verdict
would survive Defendants’ inevitable post-trial motions and appeals. See, e.g., Hubbard v.
BankAtlantic Bancorp, Inc., 688 F.3d 713, 730 (11th Cir. 2012) (overturning jury verdict for
plaintiffs).
Plaintiffs also faced the risk of being unable to collect on a judgment against Cloopen
because its financial status and ability to withstand a greater judgment than the recovery here is, at
a minimum, questionable, if not in serious doubt. On May 17, 2023, the New York Stock Exchange
suspended the trading of Cloopen ADS for the Company’s failure to file annual reports with the
U.S. Securities and Exchange Commission (“SEC”) for years ended December 31, 2021, and
December 31, 2022. Cloopen ADSs stock are currently trading at $0.00010 (as of December 18,
2023) and have been trading under $1 per ADS since May 31, 2023. Joint Aff., ¶70. Further,
because Cloopen is a China-based company and appears to have no significant assets in the United
States (or elsewhere outside of China), and because Cloopen and its officers had no insurance
policy applicable to the claims here, collectability issues were a major additional risk. Joint Aff.,
¶71. In addition, the United States and China have no treaties providing for enforcement of
judgments rendered in each other’s courts. Indeed, courts in China are seldom known to recognize
and enforce United States civil court judgments. Joint Aff., ¶72.
8
14 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
Although collectability is not an issue as to the Underwriter Defendants, those defendants
(unlike Cloopen) would have been able to assert a “due diligence” defense by arguing that they
reasonably relied on Cloopen’s assurances with regard to any allegedly misstated or omitted
matters. A due diligence defense is difficult to overcome. See Fed. Hous. Fin. Agency, 873 F.3d
at 125 (noting that “we are aware of only two other federal decisions [. . .] holding on summary
judgment that a Section 12 defendant cannot pursue [a due diligence] defense”). In addition, the
Underwriter Defendants here, like in similar cases, claim to be indemnified by the security issuer,
Cloopen. Joint Aff., ¶73.
While Plaintiffs maintain that the Settlement Class’s claims are meritorious, Defendants
have steadfastly maintained throughout the case that the claims are meritless. In addition to the
other numerous hurdles to establishing Defendants’ liability and damages, the Actions lack several
of the hallmarks of a typical, successful securities action. For example, there was no restatement
of financial results prior to the settlement, no SEC investigation, and no criminal indictment on
which Plaintiffs could “piggy-back.” Indeed, the Actions presented several unusual risk factors due
to the difficulties of taking depositions and conducting document discovery in China, as detailed
above, and of enforcing a favorable judgment in China even if the evidence to establish liability
against Cloopen could be obtained. Joint Aff., ¶¶60-74.
In assessing the adequacy of a settlement, courts also weigh the recovery “against the
present value of the anticipated recovery following a trial[,] [as] discounted for the inherent risks
of litigation[.]” Klein, 28 A.D.3d at 73. Here, Plaintiffs’ expert estimated that the maximum
theoretical damages under the statute were about $170 million, but that the realistic maximum
damages, given the relevant circumstances, were approximately $135 million. Importantly, this
latter figure, like any maximum damage estimate, does not take into account the bulk of
9
15 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
Defendants’ counterarguments. Joint Aff., ¶76. Indeed, as referenced above, Defendants have
argued and will likely continue to assert that their negative causation defenses would eliminate
most of the realistic damages. Id.
If one compares the proposed Settlement – $12 million – to Plaintiffs’ realistic maximum
damages of $135 million, the Settlement would result in the recovery of roughly 9% of investor
losses (and a recovery of about 7% of maximum theoretical damages) ‒ both percentages
representing a decidedly superior recovery compared to most securities settlements. Id., ¶77. For
example, NERA Economic Consulting recently reported that, between 2012 and 2022, the median
securities class action settlement equated to approximately 2.9% of maximum damages in cases
involving estimated investor losses between $100 million and $199 million.5 Likewise, even
putting percentages aside, the Settlement value here ($12 million) compares favorably to the
median securities class action settlement in the Second Circuit between 2013 and 2023 ‒ which is
$9 million.6 Moreover, the foregoing maximum damages estimates assume that Plaintiffs would
run the table on all damages questions. Defendants, however, maintain that the maximum
recoverable damages is far smaller than $135 million, which means that the percentage recovery
here is, under Defendants’ estimate, far greater than 9%. Joint Aff., ¶77. Accordingly, the
published data regarding securities class action settlements further confirms that the Settlement
represents an excellent result when compared to other securities settlements from the last decade.
5
Janeen McIntosh, et al., Recent Trends In Securities Class Action Litigation: 2022 Full-
Year Review, NERA ECON. CONSULTING, 17 (Jan. 25, 2022),
https://www.nera.com/content/dam/nera/publications/2023/PUB_2022_Full_Year_Trends.pdf.
6
Laarni T. Bulan & Laura E. Simmons, Securities Class Action Settlements: 2022 Review
and Analysis, CORNERSTONE RESEARCH, 19 (2022), https://www.cornerstone.com/wp-
content/uploads/2023/03/Securities-Class-Action-Settlements-2022-Review-and-Analysis.pdf.
10
16 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
B. Colt Factors Two Through Four: Extent of Support from the Parties,
Judgment of Counsel, and Presence of Good-Faith Bargaining
Colt factors two through four also support approval. First, the Settlement has the support
of all Parties, as evidenced by the Stipulation (NYSCEF No. 107) and Plaintiffs’ affirmations in
support of the Settlement.7 Moreover, in this context, courts also consider the reaction of absent
class members, and minimal objections and exclusions are indicative of a class’s approval of a
proposed settlement. See, e.g., Pressner v. MortgageIT Holdings, Inc., No. 602472/2006, 2007
WL 1794935, at *2 (Sup. Ct. N.Y. Cnty. May 29, 2007) (approving settlement where there were
no objections to proposed settlement); Gordon, 148 A.D.3d at 157 (holding settlement with three
objectors and 250 opt outs had “the overwhelming support” of the class). Here, although neither
the Court-established deadline for filing objections of January 2, 2024 or the deadline for filing
exclusions of December 26, 2023 has yet passed, no objections or exclusions to any aspect of the
Settlement have been submitted to date. Joint Aff., ¶59; Schachter Aff., ¶¶5, 16. Should any
objections or exclusions be filed after the date of this brief, Plaintiffs will address them on reply.
Second, Plaintiffs’ Class Counsel strongly believe that the proposed Settlement is fair,
reasonable, and adequate, particularly given the risks, costs, and uncertainties of continued
litigation and the significant collectability issues present here. Joint Aff., ¶100; see also supra
§I.A. New York courts give counsel’s views regarding settlement considerable weight, see
MortgageIT, 2007 WL 1794935, at *2, and it is respectfully submitted that the combined
experience and expertise of the Plaintiffs’ Class Counsel firms here make this factor weigh
strongly in favor of approval.
7
See the accompanying affidavit/declaration of Plaintiffs Sonny St. John (“St. John Aff.”)
(¶1) and Guozhang Wang (“Wang Decl.”) (¶1).
11
17 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
Third, the Settlement is the product of protracted, good-faith negotiations overseen by a
mediator – Robert Meyer – with extensive experience in mediating securities and other complex
class actions. See Joint Aff., ¶71. The facts here plainly reflect an arm’s-length mediation process.
The parties did not reach a quick settlement at the opening, day-long mediation session held in
February 2023. Rather, it was not until May 2023 after extended mediation and negotiation that
the Mediator made his independent “mediator’s proposal” of $12 million, which the Parties
ultimately accepted. Id., ¶53. Nor can it be seriously doubted that all Parties were at all times
represented by highly experienced counsel. Id., ¶¶6, 97.
Additionally, while negotiations continued on a separate track, the Parties continued to
press forward in litigation, including by pursuing discovery and, in the State Action, also winning
class certification and reviewing documents that certain Defendants produced. Id., ¶¶27-40. That
the Settlement was reached only after document discovery had commenced in the State Action
also further supports approval. Fiala v. Metro. Life Ins. Co., Inc., 899 N.Y.S.2d 531, 538 (Sup.
Ct., N.Y. Cnty. 2010). Thus, the “good-faith negotiation factor” strongly supports approval of the
Settlement as well. See Gordon, 148 A.D.3d at 157 (courts will presume that negotiations were
conducted at arm’s-length and in good faith absent contrary evidence).
C. Colt Factor Five: Complexity and Nature of Case
Finally, courts look to the complexity and nature of the case (which is closely related to
Plaintiffs’ likelihood of success). See Saska v. Metro. Museum of Art, 54 N.Y.S.3d 566, 570 (Sup.
Ct., N.Y. Cnty. 2017) (evaluating the first and fifth Colt factors together in granting final approval);
City Trading Fund v. Nye, 72 N.Y.S.3d 371, 393 (Sup. Ct., N.Y. Cnty. 2018) (same).
As noted above, courts have recognized the “notorious complexity” of securities class
action cases. The instant case, for example, involved: Cloopen’s performance in the rapidly
developing cloud-based computing industry in China during the global financial upheaval of the
12
18 of 27
FILED: NEW YORK COUNTY CLERK 12/19/2023 05:55 PM INDEX NO. 652617/2021
NYSCEF DOC. NO. 119 RECEIVED NYSCEF: 12/19/2023
Covid-19 pandemic; the regulatory risks posed to Cloopen’s business model by Chinese
authorities; and how such diverse factors may have impacted the price of Cloopen’s ADS –
subjects which would all have likely required specialized testimony from industry experts and
damages analysts. Joint Aff., ¶75. The numerous factual and legal complexities of both Actions
– as compounded by the procedural complications inherent in pursuing claims against a Chinese